Ergomar Tablet
Product Images NDC 81279-104

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ergomar (NDC 81279-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pangea Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2 mg Tablet Blister Pack Carton)

This is a description of Ergomar Sublingual Tablets, each containing 2 mg of Ergotamine Tartrate, USP. The tablets are manufactured in Brielle, NJ 08730, USA, by Mikart, LLC for Pangea Pharmaceuticals, LLG in Atlanta, GA 30318, USA. The text also mentions various instructions and details related to the tablets' use and ingredients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.